109 related articles for article (PubMed ID: 37145070)
1. Detection of Plasma Antibodies Against CD25-Derived Peptide Antigens in Bladder Cancer.
Du KL; Ji WT; Jiang QH; Wang Y
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145070
[TBL] [Abstract][Full Text] [Related]
2. Study of Circulating Natural Antibodies Against CD25 and FOXP3 in Type-2 Diabetes.
Qiu C; Li C; Wu X; Chen X; Zhang X; Meng Q
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776743
[TBL] [Abstract][Full Text] [Related]
3. Alteration of circulating natural autoantibodies to CD25-derived peptide antigens and FOXP3 in non-small cell lung cancer.
Zhao H; Zhang X; Han Z; Xie W; Yang W; Wei J
Sci Rep; 2018 Jun; 8(1):9847. PubMed ID: 29959381
[TBL] [Abstract][Full Text] [Related]
4. Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma.
Wang J; Xu Y; Wang Y; Zhang X; Zhang G
Onco Targets Ther; 2019; 12():10487-10493. PubMed ID: 31819529
[TBL] [Abstract][Full Text] [Related]
5. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
Wang J; Xu Y; Zhao H; Zhang X
J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
[TBL] [Abstract][Full Text] [Related]
6. A study of circulating anti-CD25 antibodies in non-small cell lung cancer.
Ye L; Li X; Sun S; Guan S; Wang M; Guan X; Lee KH; Wei J; Liu B
Clin Transl Oncol; 2013 Aug; 15(8):633-7. PubMed ID: 23263913
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
Liu S; Zhang X; Jiang Q; Liang T
FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer.
Zhang C; Ye L; Guan S; Jin S; Wang W; Sun S; Lee KH; Wei J; Liu B
Tumour Biol; 2014 Mar; 35(3):2047-51. PubMed ID: 24122232
[TBL] [Abstract][Full Text] [Related]
9. Increased Levels of Circulating Anti-ANXA1 IgG Antibody in Patients with Non-Small Cell Lung Cancer.
Liang T; Han Z; Zhao H; Zhang X; Wang Y
Clin Lab; 2018 Jun; 64(6):895-900. PubMed ID: 29945332
[TBL] [Abstract][Full Text] [Related]
10. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma.
Xu Y; Gu L; Wang J; Wang Z; Zhang P; Zhang X
Lab Med; 2020 Nov; 51(6):574-578. PubMed ID: 32195537
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer.
Wang W; Guan S; Sun S; Jin Y; Lee KH; Chen Y; Wei J
Tumour Biol; 2014 May; 35(5):4901-5. PubMed ID: 24453033
[TBL] [Abstract][Full Text] [Related]
12. Circulating autoantibody to CD25 may be a potential biomarker for early diagnosis of esophageal squamous cell carcinoma.
Guan S; Liu B; Zhang C; Lee KH; Sun S; Wei J
Clin Transl Oncol; 2013 Oct; 15(10):825-9. PubMed ID: 23423807
[TBL] [Abstract][Full Text] [Related]
13. Anti-TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population.
Li C; Whelan R; Yang H; Jiang Y; Qiu C; Meng Q; Wei J
FEBS Open Bio; 2019 Oct; 9(10):1705-1712. PubMed ID: 31336035
[TBL] [Abstract][Full Text] [Related]
14. Further analysis of natural antibodies against ischemic stroke.
Qi J; Jiang Q; Wang P; Wang Z; Zhang X
Front Neurol; 2023; 14():1130748. PubMed ID: 36741286
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Molecular Serology of Human
Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Lee DE; Kaltenboeck B
mSphere; 2018 Aug; 3(4):. PubMed ID: 30068559
[TBL] [Abstract][Full Text] [Related]
16. Investigation of circulating antibodies to ANXA1 in breast cancer.
Huang Y; Zhang C; Chen C; Sun S; Zheng H; Wan S; Meng Q; Chen Y; Wei J
Tumour Biol; 2015 Feb; 36(2):1233-6. PubMed ID: 25344217
[TBL] [Abstract][Full Text] [Related]
17. A study of type-1 diabetes associated autoantibodies in schizophrenia.
Hallford P; Clair DS; Halley L; Mustard C; Wei J
Schizophr Res; 2016 Oct; 176(2-3):186-190. PubMed ID: 27474348
[TBL] [Abstract][Full Text] [Related]
18. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
[No Abstract] [Full Text] [Related]
19. Circulating antibodies to p16 protein-derived peptides in breast cancer.
Chen C; Huang Y; Zhang C; Liu T; Zheng HE; Wan S; Sun S; Meng Q; Chen Y; Wei J
Mol Clin Oncol; 2015 May; 3(3):591-594. PubMed ID: 26137272
[TBL] [Abstract][Full Text] [Related]
20. Circulating anti-p16a IgG autoantibodies as a potential prognostic biomarker for non-small cell lung cancer.
Zhao H; Zhang X; Han Z; Wang Y
FEBS Open Bio; 2018 Nov; 8(11):1875-1881. PubMed ID: 30410866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]